Bristol-Myers Squibb Company (BMY)
58.85 x 100 59.13 x 100
Post-market by (Cboe BZX)
58.90 -0.31 (-0.52%) 03/27/25 [NYSE]
58.85 x 100 59.13 x 100
Post-market 58.91 +0.01 (+0.02%) 19:47 ET
for Thu, Mar 27th, 2025
Results
download Want to compare other data? Select Fields| Symbol | BMY | VRTX | GSK | ||
| Company | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gsk Plc ADR | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NYSE | ||
| Open | 59.18 | 498.59 | 38.32 | ||
| High | 59.56 | 506.54 | 38.67 | ||
| Low | 58.77 | 498.59 | 38.32 | ||
| Last | 58.90 | 502.55 | 38.52 | ||
| Change | -0.31 | +2.27 | +0.21 | ||
| % Change | -0.52% | +0.45% | +0.55% | ||
| Volume | 8,751,400 | 1,233,800 | 2,248,300 | ||
| 20-Day Average Volume | 13,139,210 | 1,399,150 | 4,896,155 | ||
| Previous Close | 59.21 | 500.28 | 38.31 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 60.18 | 499.10 | 39.12 | ||
| 20-Day Raw Stochastic | 18.11% | 62.49% | 37.47% | ||
| 20-Day Relative Strength | 49.58% | 57.95% | 53.63% | ||
| Weighted Alpha | +15.73 | +20.36 | -6.61 | ||
| Today's Opinion | 88% Buy | 88% Buy | 32% Buy | ||
| Previous Opinion | 88% Buy | 88% Buy | 32% Buy | ||
| Last Month's Opinion | 88% Buy | 40% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.52% since 03/20/25 | -1.50% since 03/20/25 | -2.26% since 03/20/25 | ||
| Low | 58.53 on 03/26/25 | 497.78 on 03/26/25 | 37.76 on 03/26/25 | ||
| High | 61.49 on 03/25/25 | 513.97 on 03/24/25 | 39.50 on 03/21/25 | ||
| 1-Month | |||||
| %Chg | +0.17% since 02/27/25 | +5.91% since 02/27/25 | +3.27% since 02/27/25 | ||
| Low | 57.92 on 02/28/25 | 474.01 on 02/28/25 | 37.15 on 02/28/25 | ||
| High | 63.33 on 03/11/25 | 519.68 on 03/14/25 | 40.81 on 03/10/25 | ||
| 3-Month | |||||
| %Chg | +2.12% since 12/27/24 | +22.94% since 12/27/24 | +13.03% since 12/27/24 | ||
| Low | 53.54 on 02/18/25 | 397.24 on 01/13/25 | 31.72 on 01/14/25 | ||
| High | 63.33 on 03/11/25 | 519.68 on 03/14/25 | 40.81 on 03/10/25 | ||
| 6-Month | |||||
| %Chg | +15.69% since 09/27/24 | +8.57% since 09/27/24 | -5.38% since 09/27/24 | ||
| Low | 51.03 on 09/30/24 | 377.85 on 12/19/24 | 31.72 on 01/14/25 | ||
| High | 63.33 on 03/11/25 | 519.88 on 11/08/24 | 41.80 on 10/09/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 120,155,560 | 128,466,912 | 79,293,664 | ||
| Shares Outstanding, K | 2,029,312 | 256,790 | 2,069,790 | ||
| Annual Sales | 48,300,000,000 | 11,020,100,000 | 40,095,390,000 | ||
| Annual Net Income | -8,948,000,000 | -535,600,000 | 3,290,590,000 | ||
| Last Quarter Sales | 12,342,000,000 | 2,912,000,000 | 10,387,570,000 | ||
| Last Quarter Net Income | 72,000,000 | 913,000,000 | 559,150,000 | ||
| 60-Month Beta | 0.43 | 0.41 | 0.58 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.67 on 02/06/25 | 3.98 on 02/10/25 | 0.59 on 02/05/25 | ||
| Latest Earnings Date | 04/24/25 | 05/05/25 | 05/07/25 | ||
| Most Recent Dividend | 0.620 on 01/03/25 | N/A | 0.393 on 02/21/25 | ||
| Next Ex-Dividends Date | 04/04/25 | N/A | 02/21/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 51.92 | 0.00 | 9.55 | ||